Cargando…

Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates

BACKGROUND: Inflammation and immune activation of the cervicovaginal mucosa are considered factors that increase susceptibility to HIV infection. Therefore, it is essential to screen candidate anti-HIV microbicides for potential mucosal immunomodulatory/inflammatory effects prior to further clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zalenskaya, Irina A., Joseph, Theresa, Bavarva, Jasmin, Yousefieh, Nazita, Jackson, Suzanne S., Fashemi, Titilayo, Yamamoto, Hidemi S., Settlage, Robert, Fichorova, Raina N., Doncel, Gustavo F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459878/ https://www.ncbi.nlm.nih.gov/pubmed/26052926 http://dx.doi.org/10.1371/journal.pone.0128557

Ejemplares similares

Novel Vaginal Microflora Colonization Model Providing New Insight into Microbicide Mechanism of Action
por: Fichorova, Raina N., et al.
Publicado: (2011)

Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide
por: Yamamoto, Hidemi S, et al.
Publicado: (2013)

Effects of feminine hygiene products on the vaginal mucosal biome
por: Fashemi, Bisiayo, et al.
Publicado: (2013)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

Preclinical evaluation of lime juice as a topical microbicide candidate
por: Fletcher, Patricia S, et al.
Publicado: (2008)

Differences in Local and Systemic TFV PK Among Premenopausal Versus Postmenopausal Women Exposed to TFV 1% Vaginal Gel
por: Thurman, Andrea Ries, et al.
Publicado: (2018)

Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
por: Ravel, Jacques, et al.
Publicado: (2012)

A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir
por: Thurman, Andrea R., et al.
Publicado: (2023)

Trichomonas vaginalis Lipophosphoglycan Exploits Binding to Galectin-1 and -3 to Modulate Epithelial Immunity
por: Fichorova, Raina N., et al.
Publicado: (2016)

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study
por: Thurman, Andrea R., et al.
Publicado: (2022)

The Villain Team-Up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert
por: Fichorova, Raina N, et al.
Publicado: (2013)

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
por: Nunn, Andrew, et al.
Publicado: (2009)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Characterizing the Genetic Basis for Nicotine Induced Cancer Development: A Transcriptome Sequencing Study
por: Bavarva, Jasmin H., et al.
Publicado: (2013)

The Development of Vaginal Microbicides for the Prevention of HIV Transmission
por: Weber, Jonathan, et al.
Publicado: (2005)

Vaginal deployment and tenofovir delivery by microbicide gels
por: Gao, Y., et al.
Publicado: (2015)

Baseline and time‐updated factors in preclinical development of anionic dendrimers as successful anti‐HIV‐1 vaginal microbicides
por: Rodríguez‐Izquierdo, Ignacio, et al.
Publicado: (2022)

Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides
por: Tanphaichitr, Nongnuj, et al.
Publicado: (2016)

Microbicides 2008 conference: From discovery to advocacy
por: Ramjee, Gita, et al.
Publicado: (2008)

Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety
por: Segarra, Theodore J., et al.
Publicado: (2011)

Microbicides Development Programme: Engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania
por: Vallely, Andrew, et al.
Publicado: (2009)

Regulated Expression of CCL21 in the Prostate Tumor Microenvironment Inhibits Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer
por: Yousefieh, Nazita, et al.
Publicado: (2009)

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials
por: Mâsse, Benoît R, et al.
Publicado: (2009)

Do vaginal microbicides reduce the risk of HIV acquisition in women?
por: Obiero, Jael Apondi, et al.
Publicado: (2022)

Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies
por: Thurman, Andrea Ries, et al.
Publicado: (2013)

Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission
por: Cone, Richard A, et al.
Publicado: (2006)

Analysis of Vaginal Microbicide Film Hydration Kinetics by Quantitative Imaging Refractometry
por: Rinehart, Matthew, et al.
Publicado: (2014)

Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems
por: Mesquita, Letícia, et al.
Publicado: (2019)

Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques
por: Rahman, Mohammad Arif, et al.
Publicado: (2023)

Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides
por: Herold, Betsy C
Publicado: (2006)

Increasing the Effectiveness of Vaginal Microbicides: A Biophysical Framework to Rethink Behavioral Acceptability
por: Verguet, Stéphane, et al.
Publicado: (2010)

Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota
por: O’Hanlon, Deirdre E., et al.
Publicado: (2013)

The Implications of Post-coital Intravaginal Cleansing for the Introduction of Vaginal Microbicides in South Africa
por: Gafos, Mitzy, et al.
Publicado: (2013)

G2-S16 dendrimer microbicide does not interfere with the vaginal immune system
por: Martín-Moreno, Alba, et al.
Publicado: (2019)

Surfactant Protein D Reverses the Gene Signature of Transepithelial HIV-1 Passage and Restricts the Viral Transfer Across the Vaginal Barrier
por: Pandit, Hrishikesh, et al.
Publicado: (2019)

Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges
por: Regoes, Roland R, et al.
Publicado: (2005)

Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli
por: O'Hanlon, Deirdre E, et al.
Publicado: (2010)

Quantitative assessment of microbicide-induced injury in the ovine vaginal epithelium using confocal microendoscopy
por: Vargas, Gracie, et al.
Publicado: (2012)

Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS
por: Gupta, Satish Kumar, et al.
Publicado: (2013)

An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana
por: Abdulai, Martha A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l8kucn2c8psuq57i8hbm2ab20i